Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of EMPAgliflozin on The HeterogeneitY of Ventricular Repolarization in Patients With Diabetes and Coronary HEART Disease.

NCT04117763 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT04117763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04117763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of EMPAgliflozin on The HeterogeneitY of Ventricular Repolarization in Patients With Diabetes and Coronary HEART Disease.
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
October 4, 2019
Completion date
March 31, 2024
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, cardiac, coronary heart disease, diabetes mellitus, type 2